Hiscox Ltd Share Price London S.E.
Equities
BMG4593F1207
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBX | - |
05-08 | UBS raises Centrica to 'buy' from 'neutral | AN |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.9B 389B | Sales 2025 * | 4.27B 5.37B 427B | Capitalization | 4B 5.04B 400B |
---|---|---|---|---|---|
Net income 2024 * | 470M 592M 47B | Net income 2025 * | 505M 636M 50.5B | EV / Sales 2024 * | 1.03 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.94 x |
P/E ratio 2024 * |
8.57
x | P/E ratio 2025 * |
7.87
x | Employees | - |
Yield 2024 * |
2.78% | Yield 2025 * |
3.07% | Free-Float | 92.33% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 21/04/16 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 11/05/22 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 28/02/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 15/11/17 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 19/05/15 |
Colin Keogh
BRD | Director/Board Member | 69 | 18/11/15 |
1st Jan change | Capi. | |
---|---|---|
+39.42% | 63.32B | |
+17.25% | 52.42B | |
+14.23% | 49.6B | |
+20.79% | 44.83B | |
+31.82% | 36.62B | |
+10.81% | 29.64B | |
+50.19% | 29.1B | |
+26.62% | 25.51B | |
-0.63% | 21.53B |